Cancer is a grievous disease whose treatment requires a more efficient, non-invasive
therapy, associated with minimal side effects. Gold nanoparticles possessing greatly …

Breast carcinoma is among the most commonly diagnosed cancer in females, responsible
for 15% of all cancer affiliated mortalities and 23% of all cancer incidence. Based on the …

Pancreatic cancer (PC) is a fatal disease that has a poor 5-year survival rate. The poor
prognosis can be attributed to both troublesome detections at the initial stage, which makes …

Cancer is among the leading causes of mortality in the globe. Chemotherapy utilizing
various anticancer medicines continues to be the most widely used form of treatment …

The advent of nanotechnology has opened new possibilities for bioimaging. Metal
nanoparticles (such as gold, silver, iron, copper, etc.) hold tremendous potential and offer …

Cancer is an intricate disease that develops as a response to a combination of hereditary
and environmental risk factors, which then result in a variety of changes to the genome. The …

Multi-drug resistance (MDR) developed in response to chemotherapy is one of the
prominent causes of therapeutic failure. The major underlying factors that contribute to such …

To develop next-generation nanomedicine, theranostic nanotherapeutic strategies are
increasingly being emphasized. In recent years, it is observed that the effective lifetime of …

Pancreatic cancer is the world's fourth largest causative factor of mortality with a five year of
survival rate. Poor definitive diagnosis can be ascribed to both problematic early detections …

Breast carcinoma is a molecularly diverse illness, and it is among the most prominent and
often reported malignancies in female across the globe. Surgical intervention …